LIMES SCHLOSSKLINIKEN AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 359 EUR | -0.83% |
|
+2.84% | +27.46% |
| 05-13 | LIMES Schlosskliniken AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-06 | LIMES Schlosskliniken AG Provides Earnings Guidance for the First Half and Year 2024 | CI |
| Sales 2024 * | 43.29M 46.46M 3.67B | Sales 2025 * | 55.98M 60.08M 4.74B | Capitalization | 106M 114M 9B |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2.45 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.9 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 207 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 23.1% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -0.83% | ||
| 1 week | +2.84% | ||
| Current month | +5.23% | ||
| 1 month | +5.23% | ||
| 3 months | +25.69% | ||
| 6 months | +27.46% | ||
| Current year | +27.46% |
1 week
352.00
362.00
1 month
330.00362.00
Current year
274.00362.00
1 year
238.00378.00
3 years
144.00386.00
5 years
80.00386.00
10 years
80.00386.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 30/11/05 | |
| Chief Tech/Sci/R&D Officer | - | - | |
Sophia Just
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 30/11/05 | |
Dirk Isenberg
CHM | Chairman | 58 | 13/06/19 |
| Director/Board Member | 59 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/06/24 | 362 | +0.56% | 37 |
| 20/06/24 | 360 | +1.12% | 6 |
| 19/06/24 | 356 | 0.00% | 9 |
| 18/06/24 | 356 | +1.71% | 9 |
| 17/06/24 | 350 | -0.57% | 41 |
Delayed Quote Xetra, June 21, 2024 at 04:36 pm
More quotes
Limes Schlosskliniken AG is a Germany-based company. The Company engages in the Operation of clinics and healthcare facilities. This includes the provision of management and administrative services for other companies, in particular clinic operating companies, as well as businesses that directly serve and promote this company purpose.
Calendar
02/09/2024
- Q2 2024 Earnings Release
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
362
EUR
Average target price
632
EUR
Spread / Average Target
+74.59%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +27.46% | 113M | |
| -31.73% | 13.83B | |
| +2.49% | 11.55B | |
| -7.21% | 11.13B | |
| +9.74% | 10.61B | |
| +27.19% | 8.54B | |
| -9.09% | 7.36B | |
| +7.87% | 6.83B | |
| +7.87% | 6.65B | |
| +15.70% | 4.41B |
- Stock Market
- Equities
- LIK Stock
